ArticleRisk management and healthcare policy2026
Global, Regional, National and HDI-Stratified Burdens of Intraocular Foreign Bodies from 1990 to 2021: A Trend Analysis.
Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to analyze global trends and disparities in the incidence and burden of intraocular foreign bodies (IOFBs) from 1990 to 2021 across 204 countries and territories, stratified by region, age, sex, socio-demographic index (SDI) and human development index (HDI), while assessing the impact of the COVID-19 pandemic. Methods: Utilizing data from the Global Burden of Disease Study 2021 (GBD 2021), we extracted the age-standardized incidence rates (ASIR), years lived with disability (YLDs), and the number of cases of IOFBs. Estimated annual percentage changes (EAPC) were calculated to evaluate trends. Results: Globally, the number of IOFB cases increased by 33% (21.59 to 28.67 million) from 1990 to 2021. While ASIR declined overall (EAPC: -0.99), an upward trend emerged post-2010. High-SDI regions and very high HDI countries exhibited the highest ASIR, whereas low-SDI regions saw the largest case growth (129%). Males aged 25-54 years comprised the majority of cases. COVID-19 altered injury patterns, shifting incidents to domestic settings. Regions like East Asia and Brazil demonstrated significant ASIR reductions, while Central Latin America experienced rising trends. Similarly, regions and countries such as East Asia and Brazil showed significant decreases in YLDs rate, while Southeast Asia and the Philippines showed a slight upward trend. Conclusion: Despite the current decline in ASIR from 30 years ago, it has shown an upward trend since 2010, indicating that IOFBs is an ongoing public health challenge. Disparities due to socioeconomic development, occupational risks, demographic factors, and epidemics necessitate targeted interventions. In the future, strengthening occupational regulations, healthcare capacity, and data-driven prevention strategies appear quite necessary.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.